Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysis

Open access
Rowlands, Mari‐Anne, Gunnell, David, Harris, Ross, Vatten, Lars J., Holly, Jeff M.P., Martin, Richard M. · 2009 · International Journal of Cancer

Abstract

Insulin‐like growth factors (IGF‐I, IGF‐II) and their binding proteins (IGFBP‐1–6) play a key role in cell proliferation, differentiation and apoptosis, suggesting possible involvement in carcinogenesis. Several epidemiological studies show associations of IGFs with prostate cancer. We searched the published literature for all studies relating levels of IGFs or IGFBPs with prostate cancer. We performed random effects meta‐analysis to calculate summary odds ratios. The number of studies (prostate cancer cases) included in each meta‐analysis were 42 (7,481) IGF‐I; 10 (923) IGF‐II; 3 (485) IGFBP‐1; 5 (577) IGFBP‐2; 29 (6,541) IGFBP‐3 and 11 (3,545) IGF‐1:IGFBP‐3 ratio. The pooled odds ratios (95% confidence intervals) per standard deviation increase in peptide were: IGF‐I, OR = 1.21 (1.07, 1.36); IGF‐II, OR = 1.17 (0.93, 1.47); IGFBP‐1, OR = 1.21 (0.62, 2.33); IGFBP‐2, OR = 1.18 (0.90, 1.54); IGFBP‐3, OR = 0.88 (0.79, 0.98); IGFI:IGFBP‐3 ratio, OR = 1.10 (0.97, 1.24). For all exposures, there was substantial heterogeneity (all I 2 > 75%), partly explained by study design: the magnitude of associations was smaller in prospective vs. retrospective studies, and for IGFBP‐3, the inverse association with prostate cancer risk was seen in retrospective but not prospective studies. There was weak evidence that associations of IGF‐I and IGFBP‐3 with prostate cancer were stronger for advanced disease. Our meta‐analysis confirms that raised circulating lGF‐I is positively associated with prostate cancer risk. Associations between IGFBP‐3 and prostate cancer were inconsistent, and there was little evidence for a role of IGF‐II, IGFBP‐1 or IGFBP‐2 in prostate cancer risk. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.24202

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 251

Metadata

Authors
Rowlands, M., Gunnell, D., Harris, R., Vatten, L. J., Holly, J. M. P., & Martin, R. M.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2009-03-16
Volume
124
Issue
10
Pages
2416-2429
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1987562801
Cited by
251
References
5
FWCI
2.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.